Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 29
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Amphastar Pharmaceuticals Inc
AMPH
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$26.79
0.46
1.75%
Dern. MÀJ: Oct 29, 10:18 AM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Résultats:
Résultats Q3 2026 dans dans 7 jours à partir de maintenant le jeu. nov. 5th, après la fermeture du marché
Amphastar Pharma Financials
Amphastar Pharma (AMPH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Amphastar Pharma Q2 Adj. EPS $0.91 Beats $0.62 Estimate, Sales $183.903M Beat $182.055M Estimate
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.62 by 46.77 percent. This is a 7.06 percent increase over earnings of $0.85 per share from
Benzinga Newsdesk
PRO
Amphastar Pharma Q1 Adj. EPS $0.42 Misses $0.70 Estimate, Sales $171.171M Miss $173.392M Estimate
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.70 by 40.85 percent. This is a 43.24 percent decrease over earnings of $0.74 per share from
Benzinga Newsdesk
Earnings Summary: Amphastar Pharma Q4
Benzinga Insights
PRO
Amphastar Pharma Q4 Adj. EPS $0.73 Misses $0.92 Estimate, Sales $183.105M Miss $190.480M Estimate
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.73 per share which missed the analyst consensus estimate of $0.92 by 20.82 percent. This is a 20.65 percent decrease over earnings of $0.92 per share from
Benzinga Newsdesk
Earnings Scheduled For February 26, 2026
Benzinga Insights
Insights Ahead: Amphastar Pharma's Quarterly Earnings
Benzinga Insights
